Back | Next |
home / stock / asmb / asmb message board
Subject | By | Source | When |
---|---|---|---|
whytestocks: $ASMB News Article - Assembly Bio Selects Fourth HBV Core Inhibitor Candidate for Advan | whytestocks | investorshangout | 08/18/2021 3:15:49 PM |
whytestocks: $ASMB News Article - Assembly Biosciences to Present Data from HBV Core Inhibitor Progr | whytestocks | investorshangout | 06/09/2021 8:25:49 PM |
$ASMB 1Q21 results: | DewDiligence | investorshub | 05/06/2021 9:41:36 PM |
$ASMB axes ABI-H0731 program: | DewDiligence | investorshub | 02/25/2021 9:27:08 PM |
$ASMB axes microbiome program: | DewDiligence | investorshub | 12/08/2020 10:04:19 PM |
$ASMB seems to be acknowledging that its in-house | DewDiligence | investorshub | 11/16/2020 2:22:19 PM |
* * $ASMB Video Chart 11-06-2020 * * | ClayTrader | investorshub | 11/06/2020 10:10:43 PM |
Good luck! I have no position, FWIW. | DewDiligence | investorshub | 11/06/2020 8:57:39 PM |
Another ticker a week ago$ TCDA did a | Garyst | investorshub | 11/06/2020 8:55:43 PM |
Stock down 68%, much worse than yesterday's AH session. | DewDiligence | investorshub | 11/06/2020 8:16:40 PM |
Is $ASMB now a buy? It depends! See #msg-159346890. | DewDiligence | investorshub | 11/06/2020 8:15:53 PM |
$ASMB 3Q20 results9/30/20 cash=$238M: | DewDiligence | investorshub | 11/05/2020 10:59:28 PM |
$ASMB(-37%/AH)suffers massive phase-2 failure in HBV: | DewDiligence | investorshub | 11/05/2020 10:58:09 PM |
ASMB, $ABUS collaborate on phase-2 HBV trial testing | DewDiligence | investorshub | 08/27/2020 12:36:52 PM |
$ASMB 6/30/20 cash=$226.7M2Q20 burn=$22.4M: | DewDiligence | investorshub | 08/05/2020 10:06:02 PM |
$ASMB(+10%)inks deal with BGNE for Greater-China development/commercialization | DewDiligence | investorshub | 07/20/2020 3:49:24 PM |
ASMB starts phase-2 for second-generation HBV CpAM, $ABT-H2158: | DewDiligence | investorshub | 06/25/2020 3:06:12 PM |
$ASMB 1Q20 results and HBV update | DewDiligence | investorshub | 05/07/2020 10:24:24 PM |
$ASMB 4Q19 results12/31/19 cash=$274M: | DewDiligence | investorshub | 03/04/2020 10:39:41 PM |
* * $ASMB Video Chart 12-12-2019 * * | ClayTrader | investorshub | 12/12/2019 10:36:22 PM |
News, Short Squeeze, Breakout and More Instantly...
Assembly Biosciences Inc. Company Name:
ASMB Stock Symbol:
NASDAQ Market:
Assembly Biosciences Inc. Website:
2024-07-16 14:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
– Data from both ABI-5366 and ABI-1179, novel long-acting helicase-primase inhibitor candidates for recurrent genital herpes, to be presented – – Poster presentation highlights key preclinical data from ABI-5366 supporting its entry into ongoing Phase 1a/b clinical ...
SOUTH SAN FRANCISCO, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced that the first participant has been dosed in the Phase 1b trial of ABI-4334, a nex...